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Abstract A cDNA of a type 7 adenylyl cyclase isoform was 
cloned from a bovine retinal pigment epithelium cDNA library 
using oligonucleotides developed to conserved regions common to 
mammalian adenylyl cyclases. A 6.7 kb mRNA of very high 
abundance was uniquely present on Northern blots containing 
mRNA or total RNA from the pigment epithelium. This tran- 
script was undetectable in all other tissues examined. The cDNA 
encoded a protein of 1,097 amino acids and exhibited the known 
doublet of 6 transmembrane-spanning regions in a hydrophobicity 
plot. The novel member of the type 7 adenylyl cyclase isoform was 
expressed in COS-1 cells. It was stimulated 10- and 20-fold by 
10 /.tM GTPTS and 100 /tM forskolin, respectively. The high 
expression rate exclusively in the retinal pigment epithelium sug- 
gests that this adenylyl cyclase isoform is involved in processes 
specific to this functionally exceedingly important subretinal cell 
layer. 
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1. Introduction 
To dat 9 mammalian AC isoforms (types 1 8, and 10) have 
been cloned and sequenced ([1-13]; for a review see [14]) All 
isozymes how the same pattern in their suspected membrane 
topology, i.e. two sets of 6 membrane spanning regions are 
connected via a large cytosolic loop. All isoforms are stimulated 
by the diterpene forskolin and GTP. Based on comparisons of 
amino acid similarities, types 2, 4 and 7 represent one subfamily 
of related isozymes, types 5 and 6 appear to define a second 
subfamily whereas the other isoforms, 1, 3, 8 and 10, seem to 
stand alone. An important difference between various AC 
isozymes is that they are distinctly regulated by the cz or fl~" 
subunits of the heteromeric GTP-binding proteins (G-pro- 
teins), by Ca2÷/calmodulin and by phosphorylation [15-18]. 
Although these regulatory studies have not sufficiently covered 
all isoforms to allow for an assignment into certain subgroups 
based on regulation it is becoming increasingly clear that a 
classification scheme along these lines will probably emerge. 
The functional diversity of this growing family of isozymes is 
evident from the distinct expression of particular isoforms in 
different cell types and tissues [15,19]. 
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triphosphate). 
We attempted to identify the AC isoforms which are ex- 
pressed in the bovine retina using a PCR-based strategy and 
retinal cDNA libraries. In addition to type 1, 5 and 8 AC clones 
we obtained a 1.5 kb fragment of an AC isoform which was not 
previously reported. It turned out that this PCR product was 
the result o fa  cDNA carried over from the RPE during library 
preparation. The corresponding AC full length clone was ex- 
pressed with an extraordinary tissue specificity and in high 
amounts in the RPE and not in the morphologically adjacent 
retina. 
2. Material and methods 
2.1. cDNA cloning 
Oligonucleotides used were: J399, GGGAYTGYTAYTAYTG; 
J400, TTNCCCCADATRTCRTA; J401, TGGCARTWYGAYGTN- 
TGG; J402, TCRAARTCNGCDATDATYTC; R9, GARAAGATY- 
AARACCATHGG; R10, ACIGTRTTICCCCARATRTC; KI, GC- 
CACCATGCTCCCCAGGCCGTGG; K2, GCCACCATGCCAGC- 
CAAGGGGCGC; 2U, AGGCAGGCCCCAGATGAG; AC7S, CC- 
TTCAGCYAKGGGGACCCCTCCAG; AC7A, GCAGYAGYGTG- 
TACACCACGAAGAC; (abbreviations according to the IUPAC 
code). 
Total RNA from 30 bovine retinas or 360 bovine pigment epithelia 
was isolated by isopycnic entrifugation i  Cs ÷ trifluoroacetate after 
tissue homogenization in 5.5 M guanidinium isothiocyanate [20]. RNA 
from KG-I leukemia cells and different rat tissues was prepared with 
the RNEasy kit (Qiagen). Poly(A)+RNA was enriched by chromatogra- 
phy on oligo(dT) cellulose. 
Synthesis of cDNA was accomplished with either the superscript- 
cDNA-synthesis-kit (Gibco-BRL) or A-ZAPII-cDNA-Synthesis kit 
(Stratagene). cDNAs were size fractionated (1 12 kb) and adapter- 
ligated prior to generation of oligo-(dT) primed libraries in either 2- 
ZAPIIIEeoRIICIAP (retina) or 2-ZAP-ExpresslEcoRl/XhoIlCIAP 
(RPE). 
Polymerase chain reactions were carried out in 50 j21 containing 10 
ng sscDNA, 50 pmol of each primer, 200 tiM of each dNTP and 1 U 
of Taq-DNA-Polymerase (Boehringer, Mannheim). Standard screen- 
ing and cloning procedures were used as described in [20]. Hybridiza- 
tions were for 16 h at 42°C in 5 x SSC (1 x SSC = 150 mM NaC1, 15 
mM Na-citrate, pH 7.0), 0.1% SDS, 50% formamide, 100 J2gJml dena- 
tured herring sperm DNA, 0.5% ficoll 400, 0.5% polyvinylpyrrolidone 
100, 0.5% BSA. eDNA libraries were screened with a 996 bp NcoIlXbal 
fragment prepared from a 1.5 kb PCR product which was generated 
with J399/J401 as primers and a retinal cDNA library as a template and 
subsequently J4001J402 as nested primers and 5 J21 of the foregoing 
reaction as a template. The probe was labelled by random-priming 
(DECAprime, Ambion). Filters were washed twice for 30 min at 55°C 
in 1 x SSC, 0.1% SDS. Positive single plaques were excised with ExAs- 
sist-Helper-phage and clones were obtained in the expression plasmid 
pBKCMV (Stratagene). After subcloning into pBluescript SK-. DNA 
fragments were sequenced by the dideoxy chain termination method 
[21]. 
2.2. Northern blot analysis' 
2 5/lg of poly(A)+RNA or 20/.tg total RNA isolated from the retina, 
the RPE and other tissues were run on a 0.65% agarose/formaldehyde 
gel, blotted onto nylon membranes and crosslinked by UV irradiation. 
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A Mouse-Multiple-Tissue-Northern Blotwith 2 #g mRNA from sev- 
eral tissues was purchased from Clontech (# 7762-1). The blots were 
hybridized for 24 h with the NcoIlXbaI fragment (see above, 4.8- 108 
cpm/#g DNA) and washed twice in 1 x SSC, 0.1% SDS for 30 rain at 
63°C. 
2.3. Expression of the AC in COS-1 cells" 
A 6.2 kb cDNA full length clone in pBKCMV was shortened by 
sequential digestions with KpnI, PstI and EeoRI. The truncated 4.5 kb 
clone which contained 240 bp of the Y-noncoding region and 525 bp 
5' to the first ATG start site, was ligated into the EcoRI/PstI site of the 
pCMV5 expression vector [22]. Since the start ATG triplett was not 
unambigously identifiable, Kozak sequences were placed in front of the 
first and second ATG codons, using primers K1 and K2 as sense 
primers and 2U as antisense primer. The PCR products were blunted, 
restricted with ApaI and ligated into the pCMV5-AC7-construct which 
had been treated sequentially with EeoRI, Klenow fragment and finally 
digested with ApaI. COS-1 cells were seeded into 75 cm 2 flasks and after 
2 d cells were transfected with 5 #g of supercoiled plasmid-DNA by the 
DEAE-dextran method including treatment with chloroquine and a 
DMSO shock [23]. After 3 d cells were harvested into 5 ml of phos- 
phate-buffered saline and collected by centrifugation (6,200 x g, 15 
rain). The cells were suspended inbuffer (20 mM Tris-HC1, pH 7.5, 20% 
glycerol (v/v), 1% thioglycerol, 1mM EDTA, 1 mM benzamidine, 0.1 
mM PMSF) and homogenized by passing through a 23-gauge needle 
ten times. The samples were stored at -80°C. 
2.4. A C assay 
Enzyme activity was measured for 10 min at 37°C in buffer contain- 
ing 50 mM Tris-HCl, pH 7.5, 22% glycerol (v/v), 2 mM Mn 2÷, 2 mM 
[3H]cAMP (for determination of yield) and 75 #M [e-32p]ATE cAMP 
formed was isolated by chromatography [24]. Protein determination 
was carried out with the Lowry method. 
3. Results 
3.1. Retinal adenylyl cyclases 
Using the degenerate primer pairs J399/J401 or J400/J402 
(internal primers) directed against conserved stretches of 
known mammalian ACs and a bovine retinal cDNA library as 
a template we did not amplify the expected istinct 1.8 or 1.5 
kb fragments. Using the primer pair J399/401 for the first PCR 
and J400/J402 as nested primers in a second PCR yielded an 
expected 1.5 kb band corresponding in size to a potential AC. 
Indeed, the amino acid sequence of the sequenced fragment was 
similar to mouse type 7 (76%, [10]) and human type 7 (83%, 
[25,26]) ACs. A stretch of 996 bp located between NeoI/XbaI 
sites which was most divergent at the DNA level, was used to 
screen several bovine retinal cDNA libraries. No positive 
clones were detected. However, using the degenerate AC-spe- 
cific primers R9/R10 we readily and unequivocally identified 
the expression of AC types 1, 5 and 8 at a clonal ratio of 1 : 5 : 2 
in the retina. The failure to detect any clone corresponding to 
the type 7-like fragment indicated that it either was an ex- 
tremely rare transcript or an impurity of the retinal cDNA 
library from an adjacent issue. 
3.2. Type 7 AC in the retinal pigment epithelium 
Next we prepared a Northern blot with 5 pg poly(A)+RNA 
or 20/~g total RNA from the bovine retina, the adjoining RPE 
and several other tissues and hybridized with the 996 bp DNA 
fragment (Fig. 1). Unmistakenly, the novel type 7 AC isoform 
was exclusively expressed in the RPE whereas it was undetect- 
able in all other tissues. Obviously, the transcript was very 
abundant in the RPE since it required only an overnight expo- 
sure of the hybridized blot to see a strong signal at 6.7 kb (Fig. 
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Fig. 1. Northern Blot analysis of poly(A)+RNA (5 #g/lane) or total 
RNA (20 #g/lane) of several mammalian tissues. The probe was the 
DNA stretch from basepairs 2125 to 3120. Shown is an autoradiograph 
after 16 h of exposure. Molecular size RNA markers (Gibco-BRL) are 
indicated. Individual anes contained total RNA from: (1) rat brain; 
(2) bovine retina; (3) bovine RPE; (4) rat liver; and (5) poly(A)+RNA 
from bovine RPE. In the same blot no signals were detectable with 
retina poly(A)+RNA, total RNA from KGl-human leukemia cells and 
the follwing rat tissues: kidney, thymus, heart, lymph nodes, lung, 
spleen, and testis (data not shown). 
1). An additional exposure of the blot for another 7 d indicated 
that this transcript was indeed completely absent in the retina 
and in the other tissues tested (data not shown). Further, a 
Mouse-Mult iple-mRNA blot (Clontech) with 2/.tg of poly(A) +- 
enriched RNA from kidney, skeletal muscle, liver, lung, spleen, 
brain and heart was negative (data not shown). 
Next, we used primers, R9/R10, which were developed to 
conserved regions common to all mammalian ACs and 
sscDNA from the RPE as a template in a PCR to identify all 
AC isoforms expressed in the RPE. After subcloning the PCR 
products into pBluescript and sequencing we obtained 25 
clones of the novel type 7 AC and only one single clone encod- 
ing a type 2 AC. The type 2 AC was, however, not detectable 
in bovine RPE poly(A)+RNA by northern blot analysis using 
an AC type 2 specific probe (data not shown). This demon- 
strated that the type 7-like AC isoform is probably by far the 
most abundant AC expressed in the RPE in vivo. We also 
examined whether the type 7 AC is expressed in human RPE 
using a cDNA library established from cultured human RPE 
(ATCC 77443) as a PCR template and the specific primers 
AC7S and AC7A. We easily identified the human type 7 AC 
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Fig. 2. Amino acid sequence ofbovine AC type 7 ~om bovine RPE as deduced ~om two identical ~11 length cDNA clones. The 5'- and 3'- untranslated 
regions of the cDNA clone were 525 and 2,375 bp, respectively, excluding the poly(A)-tail of 26 A's (EMBL/GenBank accession # Z49806). Underlined 
amino acid sequences indicate predicted transmembrane regions. Met-1 and Met-20 which were used as transcription start sites, are marked in bold. 
by subcloning and sequencing of the PCR product. This result 
indicated that these ACs from human and bovine RPE may be 
species variants of the type 7 AC isoform. 
3.3. Cloning and sequencing of the bovine type 7 AC 
Screening 8. l0 s plaques of the RPE-cDNA library with the 
above 996 bp AC fragment yielded 15 positive clones. Two 
full-length clones of 6.2 and 5.7 kb were completely double- 
stranded sequenced. Both had an identical ORF and coded for 
a novel type 7 AC of 1097 amino acids with a predicted molec- 
ular mass of 123,110 Da (Fig. 2). The clones only differed in 
the lengths of the 3'- and Y-untranslated regions. A canonical 
Kozak sequence was absent. The cloned AC contained the 
usual doublet of six putative transmembrane spanning regions. 
Greatest similarity was to the type 7 ACs from mouse S49- 
lymphoma cells [10] and human KG1 leukemia cells [25,26] 
with 77% and 83% identity, respectively. Thus, the cloned RPE- 
AC belongs into a subfamily of ACs which comprises types 2, 
4 and 7 isozymes which share a QXXER motif in the COOH- 
terminal region around amino acid residue 970. This sequence 
has recently been suggested to represent one of the potential 
sites for an interaction with the G-protein fly subunits [27,28]. 
Other structural features of the bovine type 7 AC isoform are 
the presence of several consensus sequences for phosphoryla- 
tion by casein kinase 2, protein kinase C, tyrosine kinase and 
cAMP-dependent protein kinase. 
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Fig. 3. Transient expression of the AC type 7 from bovine RPE in 
COS-1 cells. Met-20 was used as transcription start site. Membranes (30 
Izg) from control (pCMV5-vector alone) and pCMV5-AC-7 transfected 
COS-1 cells were assayed for AC activity as described in section 2.4. 
Values hown are the means of seven separate ransfection experiments 
with duplicate determinations of enzyme activity. 
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3.4. Expression of bovine type 7 AC in COS-1 cells 
To establish that the cloned cDNA encoded a functionally 
active AC it was attempted to express it in COS-1 cells directly 
from the cloning pBKCMV vector. This was unsuccessfull and 
may have been due to the absence of a Kozak sequence which 
also obscured the unequivocal identification of the translation 
start site. The bovine type 7 isoform carries a potential 19 
amino acid NH2-terminal extension compared to the other type 
7 isoforms mentioned above (Fig. 2). Therefore, Kozak se- 
quences were placed in front of both potential ATG start sites, 
the full-length clones were inserted into the pCMV5 expression 
vector and COS-1 cells were transfected [22]. Irrespective of the 
translation start sites, AC activity was expressed in both in- 
stances and basal activities from transfected cell homogenates 
were increased 3- to 4-fold compared to vector-transfected con- 
trol cells (10 pmol cAMP/mg). Using the construct with Met 
at position 20 (bold in Fig. 2) as a transcripiton start, 100/~M 
forskolin, 1 mM NaF and 10 ~M GTPTS stimulated basal 
activities 20-, 7.5- and 10-fold, respectively (Fig. 3). Compara- 
ble results were obtained with the 19 amino acids longer AC 
which used Met at position 1 for a transcription start (data not 
shown). We did not detect an effect of Ca 2÷ on the activity of 
the bovine type 7 isoform (tested range was 50 nM to 70/2M). 
These data agree with results obtained with other members of 
this AC subfamily, i.e. types 2 and 4 [2,4]. The presence of a 
forskolin-stimulated and G-protein-coupled AC was observed 
in homogenates from isolated bullfrog RPE [29]. Similarly, we 
detected in homogenates from isolated bovine RPE an AC 
activity which was stimulated by 100~M forskolin, 1 mM NaF 
and 10/2M GTPTS 3-, 2- and 3-fold, respectively (data not 
shown). 
4. Discussion 
This is the first structural characterization f an AC specifi- 
cally transcribed in the RPE. Its striking expression rate 
uniquely in this cell layer let us suggest that signal transduction 
via the type 7 AC is coupled to functions highly specific to the 
RPE. This layer of cells is of central importance in the func- 
tional maintenance and regeneration of the retina. It forms a 
highly differentiated monolayer of polarized cells situated at 
Bruch's membrane between the photoreceptors and the chorio- 
capillaries with the apical villous processes interdigitating with 
the outer segments of rods and cones. The RPE controls the 
transport of ions, nutrients, and fluid to the retina. Further, the 
RPE is of utmost importance for the daily phagocytotic dis- 
posal of the outer segments of rods and cones. Due to the 
uniqueness of the RPE functions it is easily conceivable that it 
contains apredominant AC isoform which is specifically geared 
to these tasks. So far, studies on the role of cAMP in the RPE 
mainly used primary cell cultures. This introduces potential 
confounding factors as placing cells in culture can alter struc- 
tural and functional characteristics. Nevertheless, many exper- 
iments with RPE cultures have convincingly implicated intra- 
cellular cAMP in the regulation of the electrical current cross- 
ing the RPE, in the transepithelial on and fluid transport, and 
in the regulation of phagocytosis of the shed disks [29-31]. 
Some of these RPE functions appear to be regulated by light 
and, therefore, must be mediated by signals from the retina [34]. 
Receptors for adenosine [32,33], dopamine [34,35], adrenaline 
[36], vasointestinal peptide [37], and melatonin [38] have been 
reported to be coupled to the AC of the RPE and to affect the 
above mentioned processes. 
The cloning of an AC which is by far the principal isoform 
in the RPE, will permit studies how these receptors are coupled 
to AC regulation, e.g. which G-proteins are involved. So far, 
enzymatic studies implicate G~ and Gi in the regulation of the 
RPE-AC [38,39]. Yet, the presence of several more G-proteins 
in the RPE has been deduced by a cloning approach [40]. 
Finally, in view of the fact that a malfunction in the interaction 
of the retina and the RPE may be involved in some forms of 
hereditary retinal degeneration [41], it may be attractive to 
consider it as a potential target enzyme. Recently, the gene for 
the human AC type 7 has been localized to chromosomal region 
16q12-16q13 [42]. While so far no gen-locus related to heredi- 
tary retinal diseases i known in this region [43] the Bardet Biedl 
syndrome, a disorder characterized by retinitis pigmentosa and 
other abnormalities, was linked to the adjacent region 16q21 
[44]. The nearly exclusive xpression of the AC type 7 in the 
RPE, the ease to prepare RPE or to use RPE cultured cells 
provide excellent conditions to study the specific physiological 
role of this isozyme. 
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